| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2971571
[patent_doc_number] => 05256415
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-26
[patent_title] => 'Vaccine against bovine respiratory disease (pasteurellosis)'
[patent_app_type] => 1
[patent_app_number] => 7/919706
[patent_app_country] => US
[patent_app_date] => 1992-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 3712
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/256/05256415.pdf
[firstpage_image] =>[orig_patent_app_number] => 919706
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/919706 | Vaccine against bovine respiratory disease (pasteurellosis) | Jul 23, 1992 | Issued |
Array
(
[id] => 3039772
[patent_doc_number] => 05376632
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-27
[patent_title] => 'Cyclodextrin based erythropoietin formulation'
[patent_app_type] => 1
[patent_app_number] => 7/906780
[patent_app_country] => US
[patent_app_date] => 1992-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6143
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/376/05376632.pdf
[firstpage_image] =>[orig_patent_app_number] => 906780
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/906780 | Cyclodextrin based erythropoietin formulation | Jun 29, 1992 | Issued |
Array
(
[id] => 3014513
[patent_doc_number] => 05332802
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-07-26
[patent_title] => 'Human collagen processing and autoimplant use'
[patent_app_type] => 1
[patent_app_number] => 7/897562
[patent_app_country] => US
[patent_app_date] => 1992-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 10602
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/332/05332802.pdf
[firstpage_image] =>[orig_patent_app_number] => 897562
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/897562 | Human collagen processing and autoimplant use | Jun 10, 1992 | Issued |
| 07/890528 | REMOVAL OF ANTIBODIES FROM BLOOD-DERIVED COMPOSITIONS WHILE RETAINING COAGULATION FACTORS | May 27, 1992 | Abandoned |
| 07/866262 | POLYPEPTIDE AND PROTEIN DERIVATIVES AND PROCESS FOR THEIR PREPARATION | Apr 9, 1992 | Abandoned |
| 07/862500 | TREATMENT OF ANOREXIA AND RELATED STATES | Apr 2, 1992 | Abandoned |
Array
(
[id] => 3071038
[patent_doc_number] => 05336666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-09
[patent_title] => 'Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae'
[patent_app_type] => 1
[patent_app_number] => 7/828855
[patent_app_country] => US
[patent_app_date] => 1992-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5450
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/336/05336666.pdf
[firstpage_image] =>[orig_patent_app_number] => 828855
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/828855 | Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae | Apr 2, 1992 | Issued |
Array
(
[id] => 2892591
[patent_doc_number] => 05272054
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-21
[patent_title] => 'Assay by enzyme-catalyzed isotopic exchange'
[patent_app_type] => 1
[patent_app_number] => 7/857883
[patent_app_country] => US
[patent_app_date] => 1992-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12799
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/272/05272054.pdf
[firstpage_image] =>[orig_patent_app_number] => 857883
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/857883 | Assay by enzyme-catalyzed isotopic exchange | Mar 25, 1992 | Issued |
| 07/849610 | HEMOGLOBIN PRODUCTS, PREPARATION AND USES | Mar 10, 1992 | Abandoned |
Array
(
[id] => 3023860
[patent_doc_number] => 05348739
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H.sub.2 -receptor agonists'
[patent_app_type] => 1
[patent_app_number] => 7/843052
[patent_app_country] => US
[patent_app_date] => 1992-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8812
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/348/05348739.pdf
[firstpage_image] =>[orig_patent_app_number] => 843052
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/843052 | Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H.sub.2 -receptor agonists | Mar 1, 1992 | Issued |
| 07/839176 | DIAGNOSIS OF CANDIDA VAGINITIS BY DETECTING D-ARABINITOL IN VAGINAL FLUID | Feb 19, 1992 | Abandoned |
Array
(
[id] => 3080329
[patent_doc_number] => 05279822
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-01-18
[patent_title] => 'Monoclonal antibodies against the 28KD protein of S. mansoni'
[patent_app_type] => 1
[patent_app_number] => 7/836725
[patent_app_country] => US
[patent_app_date] => 1992-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2581
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/279/05279822.pdf
[firstpage_image] =>[orig_patent_app_number] => 836725
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/836725 | Monoclonal antibodies against the 28KD protein of S. mansoni | Feb 18, 1992 | Issued |
Array
(
[id] => 2991993
[patent_doc_number] => 05346992
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-13
[patent_title] => 'Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN\'s fraction V or from an analogous supernatant or fraction'
[patent_app_type] => 1
[patent_app_number] => 7/832081
[patent_app_country] => US
[patent_app_date] => 1992-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1614
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/346/05346992.pdf
[firstpage_image] =>[orig_patent_app_number] => 832081
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/832081 | Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction | Feb 5, 1992 | Issued |
Array
(
[id] => 3945593
[patent_doc_number] => 05977069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => 1
[patent_app_number] => 7/827178
[patent_app_country] => US
[patent_app_date] => 1992-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2452
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977069.pdf
[firstpage_image] =>[orig_patent_app_number] => 827178
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/827178 | Pharmaceutical formulation | Jan 27, 1992 | Issued |
Array
(
[id] => 3092397
[patent_doc_number] => 05290764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-01
[patent_title] => 'Stabilization of active plasminogen activator inhibitor-1'
[patent_app_type] => 1
[patent_app_number] => 7/820523
[patent_app_country] => US
[patent_app_date] => 1992-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6912
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/290/05290764.pdf
[firstpage_image] =>[orig_patent_app_number] => 820523
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/820523 | Stabilization of active plasminogen activator inhibitor-1 | Jan 13, 1992 | Issued |
Array
(
[id] => 3006853
[patent_doc_number] => 05281416
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-01-25
[patent_title] => 'Swine dysentery vaccine'
[patent_app_type] => 1
[patent_app_number] => 7/809202
[patent_app_country] => US
[patent_app_date] => 1991-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 19
[patent_no_of_words] => 5253
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/281/05281416.pdf
[firstpage_image] =>[orig_patent_app_number] => 809202
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/809202 | Swine dysentery vaccine | Dec 11, 1991 | Issued |
Array
(
[id] => 2979154
[patent_doc_number] => 05250298
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-10-05
[patent_title] => 'Live attenuated newcastle disease virus vaccines and preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 7/808046
[patent_app_country] => US
[patent_app_date] => 1991-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5395
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/250/05250298.pdf
[firstpage_image] =>[orig_patent_app_number] => 808046
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/808046 | Live attenuated newcastle disease virus vaccines and preparation thereof | Dec 11, 1991 | Issued |
Array
(
[id] => 3048131
[patent_doc_number] => 05304638
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-04-19
[patent_title] => 'Protein separation medium'
[patent_app_type] => 1
[patent_app_number] => 7/777531
[patent_app_country] => US
[patent_app_date] => 1991-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8365
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/304/05304638.pdf
[firstpage_image] =>[orig_patent_app_number] => 777531
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/777531 | Protein separation medium | Dec 3, 1991 | Issued |
Array
(
[id] => 3033356
[patent_doc_number] => 05300422
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-04-05
[patent_title] => 'Screening method for controlling agranulocytosis'
[patent_app_type] => 1
[patent_app_number] => 7/802162
[patent_app_country] => US
[patent_app_date] => 1991-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1600
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/300/05300422.pdf
[firstpage_image] =>[orig_patent_app_number] => 802162
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/802162 | Screening method for controlling agranulocytosis | Dec 3, 1991 | Issued |
| 07/800890 | PRODUCTION OF STREPTOCOCCAL M PROTEIN | Nov 26, 1991 | Abandoned |